Kestra Advisory Services’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$894K Buy
62,246
+60,546
+3,562% +$899K ﹤0.01% 1812
2025
Q4
$25.6K Buy
+1,700
New +$25.5K ﹤0.01% 4380
2023
Q1
Sell
-22,590
Closed -$349K 2090
2022
Q4
$349K Buy
22,590
+11,695
+107% +$181K ﹤0.01% 1636
2022
Q3
$163K Sell
10,895
-2,472
-18% -$40.9K ﹤0.01% 1910
2022
Q2
$220K Sell
13,367
-24,155
-64% -$414K ﹤0.01% 1843
2022
Q1
$753K Sell
37,522
-10,179
-21% -$211K 0.01% 1079
2021
Q4
$1.21M Sell
47,701
-21,058
-31% -$544K 0.01% 894
2021
Q3
$1.85M Sell
68,759
-8,712
-11% -$249K 0.02% 746
2021
Q2
$2.24M Sell
77,471
-6,932
-8% -$192K 0.03% 607
2021
Q1
$2.22M Buy
84,403
+62,967
+294% +$1.79M 0.03% 563
2020
Q4
$610K Buy
+21,436
New +$570K 0.01% 1102

Other funds holding BMEZ

Kestra Advisory Services's BMEZ Position: Q1 2026 in Review

Kestra Advisory Services increased its BlackRock Health Sciences Trust II (BMEZ) stake by 3,562% in Q1 2026, buying an estimated $899K and bringing the position to 62,246 shares worth $894K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Kestra Advisory Services first reported a position in BMEZ in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.24M in Q2 2021. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Kestra Advisory Services held 62,246 shares of BlackRock Health Sciences Trust II worth $894K as of Q1 2026.
  • Kestra Advisory Services bought 60,546 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $899K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #1812 holding.
  • Kestra Advisory Services first reported a position in BlackRock Health Sciences Trust II in Q4 2020 and has held it in 11 quarters since.
  • Kestra Advisory Services's BlackRock Health Sciences Trust II position peaked at $2.24M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.